 |
|
|
 |
Common Hypertension Drug Could Delay Disability In Elderly
A group of commonly prescribed hypertension drugs shows promise for delaying muscle loss and disability in older adults, report researchers from Wake Forest University Baptist Medical Center in last week's issue of The Lancet. more
|
|
Congestive Heart Failure In The United States: An Epidemic
An estimated 4.8 million Americans have congestive heart failure (CHF). Increasing prevalence, hospitalizations, and deaths have made CHF a major chronic condition in the United States. It often is the end stage of cardiac disease. Half of the patients diagnosed with CHF will be dead within 5 years. Each year, there are an estimated 400,000 new cases. The annual number of deaths directly from CHF increased from 10,000 in 1968 to 42,000 in 1993, with another 219,000 related to the condition. more
|
|
|
|
Researchers Develop First Oral Drug To Treat Smallpox Infection
An oral drug that halts the deadly action of smallpox and related orthopox viruses in lab tissue culture cells and in cowpox-infected mice has been developed by researchers at the Veterans Affairs San Diego Healthcare System (VASDHS) and the University of California, San Diego (UCSD) School of Medicine, and is being evaluated by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). more
|
|
Treating Eye Pain May Remove Other Migraine Symptoms
Eye pain is often a co-symptom of migraine sufferers. Researchers have found that treating inflammation in the eye's trochlea tendon can relieve the headache pain associated with migraines, or prevent the triggering of full-blown migraine attacks. The study of five migraine patients with trochleitis (inflammation of the trochlea tendon) is reported in the current issue of Neurology, the scientific journal of the American Academy of Neurology. more
|
|
Clinical Trials For HIV/AIDS Therapies Break New Ground
The Institute of Human Virology (IHV), a center of the University of Maryland Biotechnology Institute led by internationally renowned Robert Gallo, M.D., this month opens two innovative clinical trials, one utilizing a pharmaceutically-produced compound based on a naturally-occurring substance (called chemokines) that can block the HIV virus and halt the progression of AIDS, a Gallo discovery that was hailed by Science magazine in 1996 as one of that year's most important scientific breakthroughs. more
|
|
|
